The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Insulet Corporation (NASDAQ: PODD) is one of the best NASDAQ stocks with high upside potential. On June 6, Insulet announced promising new clinical trial results for its next-generation tubeless Automated Insulin Delivery/AID systems, presented at the American Diabetes Association’s 86th Scientific Sessions. The STRIVE pivotal trial for the upcoming Omnipod 6 showed strong glycemic outcomes and improved responsiveness to hyperglycemia, noting that the system can deliver up to 50% more automated insulin while reducing the need for manual boluses across various age groups and diabetes types.

The company also shared findings from the EVOLUTION 3 feasibility study, which focused on a fully closed-loop system specifically for type 2 diabetes. This technology is designed to automatically adjust insulin levels without requiring manual user settings, aiming to simplify clinical workflows and remove traditional barriers to care for individuals with type 2 diabetes.

These developments align with Insulet Corporation’s (NASDAQ:PODD) broader innovation strategy, which prioritizes technology that requires less daily effort from users while simultaneously improving health outcomes. By combining these advanced AID systems, the company aims to move closer to a future where managing diabetes is significantly more automated and accessible for a wider range of patients.

Insulet Corporation (NASDAQ:PODD) is a medical device company focused on developing, manufacturing, and selling insulin delivery systems for patients with diabetes.

While we acknowledge the potential of PODD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.